Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID‐19
Vui Heng Chong, Pui Lin Chong, Dhiya Metussin, Rosmonaliza Asli, Riamiza Natalie Momin, Babu Ivan Mani, Muhammad Syafiq Abdullah
Abstract
Conduction abnormalities in hydroxychloroquine add on therapy
Topics & Concepts
HydroxychloroquineLopinavir/ritonavirLopinavirVirologyCoronavirus disease 2019 (COVID-19)RitonavirMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antiretroviral therapyViral loadHuman immunodeficiency virus (HIV)Internal medicineOutbreakDiseaseInfectious disease (medical specialty)Pharmacological Effects and Toxicity StudiesDrug-Induced Ocular ToxicityBlood disorders and treatments